Published on

Epic Research is a leading financial services provider with presence in Indian and other global capital markets. Provides Stock Tips, Forex Tips, Commodity Tips, MCX Tips, Equity Tips, Tips, Intraday Tips, NSE Tips, BSE Tips, COMEX Tips, PCG Pack and NCDEX Tips. We provide services in equity, commodity and Forex market.

  • Be the first to comment

  • Be the first to like this

No Downloads
Total views
On SlideShare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide


  1. 1. HEADLINES  Indian Market Indian equity markets ended flat. Nifty down by 1.15 pts and settle at 5626.60 Sensex down by 10.77 pts at 18506.57. Bank Nifty down by 32.55 pts at 11475.80 DAILY EQUITY  Global Market NEWSLETTER European markets were up with FTSE TH up by 6.87 pts at 5797,CAC down by 3497 26 NOVEMBER 2012 pts and DAX up by 1.00 pts at 7245.99 Dow future up by 22.00 pts at 12822.00  HEADLINES• SEBI seeks info on IPO probe, warnspenalty against DLF• Ranbaxy recalls Atorvastatin from USmarket, stock slips 2%• Siemens Q4 PAT seen up 9% at Rs 195crore• Nifty ends flat; Hindustan Copper, BlueDart offers fully subscribed WWW.EPICRESEARCH.CO 09752199966
  2. 2.  MARKET ANALYSIS:  Key benchmark indices registered small losses in choppy trading sessions. The market breadth was negative. The barometer index, BSE Sensex, lost 10.77 points or 0.06%, up close to 105 points from the days low and off close to 50 points from the days high. Index heavyweight and cigarette maker ITC edged lower. Another index heavyweight Reliance Industries (RIL) edged higher. Realty stocks edged lower. In banking pack, HDFC Bank hit record high. Aviation shares surged. Ranbaxy Laboratories declined after the company said it has made a recall of Atorvastatin from the US market which will cause temporary disruption to that market of this product.The BSE Sensex was up 48.15 points or 0.26% to 18,508.53.  The S&P CNX Nifty shed 1.15 points or 0.02% to 5,626.60,  From the 30-share Sensex pack, 18 stocks fell while the rest of them rose.  CICI Bank fell 0.72%. ICICI Banks net profit jumped 30% to Rs 1956 crore in Q2 September 2012 over Q2 September 2011. Net interest income jumped 35% to Rs 3371 crore and non-interest income jumped 17% to Rs 2043 crore in Q2 September 2012 over Q2 September 2011. Net interest margin improved to 3% in Q2 September 2012 from 2.61% in Q2 September 2011. Cost-to-income ratio reduced to 40.9% in Q2 September 2012 from 44.4% in Q2 September 2011. The result was announced on 26 October 2012.of India, and Bank of Baroda gained by between 0.38% to 1.65% Tyre shares gained across the board. Apollo Tyres, JK Tyre & Industries, MRF and CEAT rose by between 0.51% to 3.05%. STOCKS TO WATCH  FII’s and DII’s  HEXAWARECATEGORY DATE BUY SELL NET  JP ASSOSIATE 23-Nov-2012 1736.16 1369.79 366.37  EXIDE FII 23-Nov-2012 532.64 716.91 -184.27  IRB INFRA DII SCRIPS IN BAN PERIOD  NIFTY DAILY PIVOTS  SUZLONPIVOT R4 R3 R2 R1 PP S1 S2 S3 S4NIFTY 5775 5725 5625 5652 5624 5602 5574 5524 5474  PUNJLYOD  WELCORP  HDIL  RENUKA WWW.EPICRESEARCH.CO 09752199966
  3. 3. .  GAINERS AND LOOSERS EXPERT OPINION NIFTY DAILY NIFTY GAINERS  Nifty looks ConsolidatedSCRIPS RATE VOL. PR. NET %  Strategy: Buy on dips (000) CLOSE CHAN CHANG GE E  Support:5602 Asian 4054.1 75.8 3968.05 86.05 2.17  Resistance: 5652Paints BHEL 224.7 2438.12 221.3 3.4 1.54 BANK NIFTY  Bank Nifty looks consolidated HCL 636.45 1746.31 627.3 9.15 1.46Tech.  Strategy: Buy on dips Hero 1825.25 211.3 1803.3 21.95 1.22MotoCo.  Support:11413 530.2 1034.97 524.35 5.85 1.12  Resistance:11571Hindustan Unilever PREVIOUS PERFORMANCE TYPE SCRIP B/S RESULT DAILY NIFTY LOOSERS NOTSCRIPS RATE VOL. PR. NET % CASH APTECH S EXECUTED (000) CLOSE CHAN CHA JP NOT CASH B GE NGE ASSOCIATE EXECUTED Ranbaxy 495.95 191.81 512.7 -16.75 -3.27 TGT FUTURE AMBUJA B Labs. ACHEIVED NTPC 159.5 662.71 163.7 -4.2 -2.57 TATA TGT FUTURE S MOTORS ACHEIVED Grasim 3179.15 3.49 3243.8 -64.65 -1.99IndustriesGAIL India 340 35.59 346.75 -6.75 -1.95 NMDC 166.5 48.77 169.7 -3.2 -1.89 09752199966
  4. 4. MARKET CALLS CASH ST ND SCRIPS ACTION LEVEL 1 TARGET 2 TARGET STOP LOSS EXIDE BUY 140.10 141.20 143.30 138.95 HEXAWARE SELL 100.90 100 99 101.80 FUTURE ST ND SCRIPS ACTION LEVEL 1 TARGET 2 TARGET STOP LOSS. IRB INFRA BUY 123.40 124.40 125.90 122.40 JP ASSOSIATE SELL 88.50 88 87.30 89.05 Disclaimer The information and views in this report, our website & all the service we provide are believed to be reliable, but we do not accept any responsibility (or liability) for errors of fact or opinion. Users have the right to choose the product/s that suits them the most. Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up on sources that we consider reliable. This material is for personal information and based upon it & takes no responsibility The information given herein should be treated as only factor, while making investment decision. The report does not provide individually tailor-made investment advice. Epic research recommends that investors independently evaluate particular investments and strategies, and encourages investors to seek the advice of a financial adviser. Epic research shall not be responsible for any transaction conducted based on the information given in this report, which is in violation of rules and regulations of NSE and BSE. The share price projections shown are not necessarily indicative of future price performance. The information herein, together with all estimates and forecasts, can change without notice. Analyst or any person related to epic research might be holding positions in the stocks recommended. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views expressed as a recommendation for which either the site or its owners or anyone can be held responsible for . Any surfing and reading of the information is the acceptance of this disclaimer. All Rights Reserved. Investment in equity & bullion market has its own risks. We, however, do not vouch for the accuracy or the completeness thereof. we are not responsible for any loss incurred whatsoev er for any financial profits or loss which may arise from the recommendations above epic research does not purport to be an invitation or an offer to buy or sell any financial instrument. Our Clients (Paid Or Unpaid), Any third party or anyone else have no rights to forward or share our calls or SMS or Report or Any Information Provided by us to/with anyone which is received directly or indirectly by them. If found so then Serious Legal Actions can be taken.